Advertisement

Topics

Vaxelis approval boosts Merck and Sanofi’s foothold in US childhood vaccines

09:49 EST 11 Jan 2019 | Pharmaceutical Technology

In late December, Merck and Sanofi secured FDA approval for Vaxelis (diphtheria, tetanus, and acellular pertussis [DTaP]-inactivated poliovirus [IPV]-haemophilus b...
Read More...

The post Vaxelis approval boosts Merck and Sanofi’s foothold in US childhood vaccines appeared first on Pharmaceutical Technology.

Original Article: Vaxelis approval boosts Merck and Sanofi’s foothold in US childhood vaccines

NEXT ARTICLE

More From BioPortfolio on "Vaxelis approval boosts Merck and Sanofi’s foothold in US childhood vaccines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...